ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients…
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical…
Subtle Medical's new software is now available for clinical use in the US, further redefining the speed and quality of…
PALO ALTO, CA / ACCESSWIRE / July 17, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is pleased…
VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to…
MINNEAPOLIS, July 16, 2024 /PRNewswire/ -- MNGI Digestive Health ("MNGI") has learned of a data security incident that may have…
SenderraCare+ is a game-changer for providers and patients alike. It simplifies the time-consuming process and offers a real-time digital solution…
NEW YORK, July 16, 2024 /PRNewswire/ -- The global industrial laser market size is estimated to grow by USD 2.89…
How one employee's upbringing and career journey have motivated her to fight inequities around the world NORTHAMPTON, MA / ACCESSWIRE…
WASHINGTON, DC / ACCESSWIRE / July 16, 2024 / The Alliance for Safe Biologic Medicines (ASBM) announces the publication of…